Women's health-focused specialized telemedicine provider Maven Clinic has raised USD 125 million in a Series F funding round led by StepStone Group. General Catalyst, Sequoia, Oak HC/FT, Icon Ventures, Dragoneer Investment Group, and Lux Capital participated in the round. The funding brings Maven's total funding to over USD 425 million. At the time of the funding, the company was valued at USD 1.7 billion.

The capital will invest in Maven's fertility benefits administration and virtual care delivery platforms, enhance AI-powered solutions, bolster value-based offerings in maternity care across commercial and Medicaid populations, and expand support for healthy aging and menopause care.

Maven's Maternity & Newborn Care program has experienced over 400% client growth in the past year, while its Menopause & Midlife program is the fastest-growing global program with 300% YoY growth. As of October 2024, the company serves more than 2,000 clients across 175 countries, including major corporations like Amazon, Microsoft, and AT&T.

Analyst QuickTake: In April 2024 , Maven expanded its offerings, launching its Trying-To-Conceive (TTC) health coaching program. Additionally, as part of an expansion, it is adding a range of specialist types to its reproductive urology provider network and expanding access to provider types for male fertility care. With this recent fundraise, the company appears to be expanding its offerings to address other niche areas of care.